

By Brendan Pierson Sept 24 (Reuters) - A U.S. appeals court has upheld drugmaker Shire's patents for its top-selling drug Vyvanse, blocking five gener...


(ShareCast News) - UK stocks finished the session with slight gains, tracking the ebb and flow of trading Stateside as analysts continued to weigh in ...


(ShareCast News) - Shire chief Flemming Ornskov is still keen on pursuing inorganic growth, which analysts at Barclays believe caps downside risks in ...